ClearCam announces FDA clearance of Kelling Laparoscopic Lens Cleaning Device

ClearCam announces FDA clearance of Kelling Laparoscopic Lens Cleaning Device

ClearCam introduces their “windshield wiper for a laparoscope”

ATI member ClearCam, Inc., the company dedicated to maximizing clinician vision and skill in the operating room, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the ClearCam Laparoscopic Lens Cleaning Device, known as ClearCam Kelling. The Kelling Device (Kelling) is a simple, mechanical, and efficient disposable in-vivo laparoscopic lens cleaner that eliminates the need for clinicians to continually remove the scope from the patient’s body to clean it during surgery. Kelling allows surgeons to maintain their visual field throughout the case thereby reducing frustration from interruptions. Surgeons can focus solely on the procedure and on the patient and utilize today’s high resolution and advanced minimally-invasive technologies as they are meant to.

“Receiving FDA clearance on Kelling is a significant step in ClearCam’s commitment to improving visualization for clinicians in the OR” stated President and COO Doug Stoakley. “Kelling is the first of many products we are working on in our pipeline and we look forward to sharing new developments with clinicians in the coming months. Now, however, we are focused on getting Kelling to market and into the hands of surgeons.”

Kelling will be initially available in 5mm angled and flat versions with 10mm versions arriving in early 2021. The product simply slides over the scope, anchors to the light port, and is inserted into the trocar as a clinician would normally do. No proprietary equipment, no cords or tubes, and no impact to the standard OR workflow or setup. Kelling’s U.S. launch is planned for late summer 2020.

“We are excited to bring Kelling into the OR as soon as possible” said ClearCam CEO Dr. John Uecker, FACS. “When I brought this problem to Professor Chris Rylander’s Biodesign class at UT Austin in 2016, and Dr. Chris Idelson picked the challenge up, I could not have foreseen that we would, just 4 years later, have an FDA cleared product to help clinicians see better.”

About ClearCam Inc.

ClearCam™  Inc. is dedicated to improving laparoscopic surgery patient outcomes by reducing surgical team frustration, shortening surgical procedures, and lowering costs by maximizing the visualization platform. The company is preparing to raise a Seed Series “B” round of funding in Spring of 2020. In addition to its membership in the Austin Technology Incubator, ClearCam is a proud affiliate/alum of the Dell Medical School at the University of Texas at Austin, The Cockrell School of Engineering at the University of Texas at Austin and their Innovation Center, The Texas Health Catalyst, and the MedTech Innovator Accelerator. Currently ClearCam has offices at MedtoMarket (www.medtomarket.com) and a cleanroom at the ACC Bioscience Incubator in Austin, Texas. They can be contacted at www.clearcam-med.com.